-
Do you know what these joint examinations need to be done for rheumatic patients
Time of Update: 2022-11-04
In the process of treatment, joint ultrasound examination can also help doctors predict the efficacy and imaging progress of drugs, so that doctors can more accurately understand disease activity, closely monitor disease changes, evaluate efficacy and judge prognosis, providing an important basis for formulating reasonable rheumatoid treatment plans.
-
How to correctly interpret the results of the "C peptide release test", an important means of assessing islet function
Time of Update: 2022-09-21
Principles of C peptide release assayLet the patient quantify oral glucose (or steamed meal) on an empty stomach, raise blood sugar, stimulate insulin β cells to release C peptide and insulin, and determine the level and change of plasma C-peptide at different time points after fasting and sugar to understand the reserve function of islet β cells.
-
The innovation and development of the traditional Chinese medicine industry requires both "soft and hard
Time of Update: 2022-02-17
At the same time, it also stated that it will accelerate the research and development of products in related fields in terms of traditional Chinese medicine innovation, and continuously improve the added value of products .
-
Sub-Journal of "Science": New-concept drug shields can solve the side effects of anticancer drugs
Time of Update: 2021-09-30
The study published by Tang's team in Science Advances shows a new method that allows immunotherapy molecules to be activated only when they encounter a tumor .
The researchers said that this method allows the drug to specifically attack the tumor without damaging normal tissues .
-
Innovative postoperative analgesic drug Zynrelef is approved by the U.S. FDA
Time of Update: 2021-07-06
On Thursday, the FDA approved Heron’s dual-acting anesthetic product Zynrelef, a sustained-release combination product composed of the local anesthetic drug bupivacaine and the anti-inflammatory drug meloxicam .
Heron plans to use Zynrelef as an alternative to opioid drugs for postoperative pain relief .
-
Replace opioids
Time of Update: 2021-05-23
Heron plans to use Zynrelef as an alternative to opioid drugs for postoperative pain relief.
Reference source: Heron's troubled opioid alternative for post-surgery pain takes flight with FDA nod
Reference source: Heron's troubled opioid alternative for post-surgery pain takes flight with FDA nod
-
China's drug market will reach 1.71 trillion yuan
Time of Update: 2021-02-16
2015-2017, the share of chronic drug use in grade hospitals has gradually declined, and the size and share of primary health care institutions and retail pharmacies has been increasing, with the growth rate of chronic drug use in retail pharmacies exceeding 10%.
-
Focus on Zhangjiang, and Huang Pharmaceutical's largest innovative pharmaceutical production base started
Time of Update: 2020-12-18
The entire construction will be divided into two phases, with a total construction area of nearly 55,000 square meters, the first phase is mainly for the production of small molecular compounds, after completion of the planned annual production capacity of up to 250 million tablets, 550 million capsules, will be used to support our global clinical and commercial supply.
-
The road to the KRAS Iron Throne, Gacus takes the lead in China
Time of Update: 2020-07-29
RaS gene mutations are genetic drivers for a variety of cancer types, including colorectal cancer, pancreatic catheteradenal cancer (PDAC), lung adenocarcinoma (LUAD; a subtype of non-small cell lung
-
What cancers can a "Trojan Horse" ADC drug that kills cancer cells
Time of Update: 2020-06-07
Several drugs have been initially used in clinical practice, and many clinical studies are being carried out JamAA Oncology, a sub-journal of the American Medical Association, recently gave a brief in
-
Drug fair from the time of the holding of the organizing committee in fertilizer to persuade the withdrawal of 9 exposed pharmaceutical companies
Time of Update: 2020-06-04
Business Agency, April 24th From April 25 to 27, the 67th National Drug Fair and the 68th China International Drug Fair will be held at the Hefei Binhu International Convention and Exhibitio
-
Phytomedicine publishes the results of Zhong Nanshan team's study on chinese medicine to treat new coronal pneumonia
Time of Update: 2020-05-28
In order to find and verify which Chinese medicines are effective in the prevention and control of the new coronaepidemic, Zhong Nanshan academician team screened more than 40 kinds of traditional Chi
-
"Shusi", a bipolar disorder drug, passed the consistency evaluation
Time of Update: 2020-02-21
BDB-001 injection for novel coronavirus pneumonia clinical trial was approved by the Ethics Committee; HIRI registered SHR-1701 phase I clinical research for advanced nasopharyngeal carcinoma; omini m
-
In 2019, FDA approval report on generic drugs: 1171 approvals set a record, 125 approvals were the "first batch
Time of Update: 2019-10-18
On Wednesday (October 16), the U.S FDA released a notice on the approval of generic drugs in fiscal 2019 FDA has been committed to promoting drug competition by increasing generic drugs In fy2019, the
-
The cross-border success of pharmaceutical enterprises should include eight elements
Time of Update: 2017-03-16
[market analysis of China Pharmaceutical network] the upsurge of cross-border pharmaceutical enterprises continues, but in many cases, there are not many successful cross-border enterprises So, what i
